🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s CAI Holdings & Trades

First Buy
Q1 2026
Duration Held
3 Quarters
Largest Add
Q3 2026
+8.15 M Shares
Current Position
8.21 M Shares
$251.49 M Value

Cliff Asness's CAI Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 8.21 M shares of Caris Life Sciences, Inc. (CAI) worth $251.49 M, representing 0.07% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.

Based on 13F filings, Cliff Asness has maintained this position in CAI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 8.15 M shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Caris Life Sciences (CAI) Holding Value Over Time

Track share changes against reported price movement

Quarterly Caris Life Sciences (CAI) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +8.15 M Add 13791.85% 8.21 M $30.63
Q2 2026 +30,109 Add 103.85% 59,103 $17.82
Q1 2026 +28,994 New Buy 28,994 $17.88

Cliff Asness's Caris Life Sciences Investment FAQs

Cliff Asness first purchased Caris Life Sciences, Inc. (CAI) in Q1 2026, acquiring 28,994 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Caris Life Sciences, Inc. (CAI) for 3 quarters since Q1 2026.

Cliff Asness's largest addition to Caris Life Sciences, Inc. (CAI) was in Q3 2026, adding 8,210,498 shares worth $251.49 M.

According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 8,210,498 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $251.49 M.

As of the Q3 2026 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.07% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Caris Life Sciences, Inc. (CAI) was 8,210,498 shares, as reported at the end of Q3 2026.